SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-010868
Filing Date
2024-04-16
Accepted
2024-04-16 16:30:33
Documents
2
Period of Report
2024-04-15

Document Format Files

Seq Description Document Type Size
1 form3-04162024_080414.html 3  
1 form3-04162024_080414.xml 3 1689
2 ex24-04162024_080414.htm EX-24 7528
  Complete submission text file 0001415889-24-010868.txt   10695
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Issuer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ACHILLION PHARMACEUTICALS, INC. 300 GEORGE STREET NEW HAVEN CT 06511
Business Address
Gibney Anthony S (Reporting) CIK: 0001750132 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37783 | Film No.: 24848183